NR2E3 mutation-associated retinal degeneration and CEP290 mutation-associated retinal disease - Pipeline Insight, 2020

  • RnM3882210
    • |
  • 14 February, 2020
    • |
  • 106 Pages
    • |
  • DelveInsight
    • |
  • Pharma & Healthcare

Make an enquiry before buying this Report



Purchase this Report

$2,000.00
$4,000.00
$6,000.00
1,546.00
3,092.00
4,638.00
1,862.00
3,724.00
5,586.00
305,380.00
610,760.00
916,140.00
168,800.00
337,600.00
506,400.00
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo